LaVoie Group Announces Second Year Serving as Global PR Agency of Record for Invida Holdings
SALEM, Mass., Jan. 17, 2011 /PRNewswire/ -- LaVoie Group, a life science and pharmaceutical focused strategic communications agency, announced today that it has been selected by Invida Holdings, the leading specialty pharmaceutical company in Asia Pacific, to continue as their 2011 global public relations agency of record. Singapore-based Invida has a presence in 13 countries in the Asia-Pacific region, and has partnered with LaVoie Group for its corporate public relations program focused on building upon its corporate identity and brand awareness as the company continues its focused expansion in key growth regions, such as China and India.
Donna L. LaVoie, President & CEO of LaVoie Group, commented, "Invida provides pharmaceutical and biotechnology partners proven brand and sales experience and a track record in bringing their products to the three billion patients in the fastest growing region in the world – the Asia-Pacific region. Under John Graham's leadership, the company has transformed itself with defining partnerships that will cement Invida's leadership in these important markets over the next several years. We look forward to growing with the company and working with the Invida team to develop and execute its global corporate communications and PR program, designed to align with Invida's business strategy and growth opportunities in these exciting markets."
John A. Graham, Chief Executive Officer of Invida, commented, "LaVoie Group has delivered and proven their expertise in the life sciences community. With the culmination of deals completed in 2010 and anticipated ones in 2011, our message will continue to be important part of our desire to acquire proprietary innovative brands for the Asian Pacific markets. LaVoie Group remains an integral part of designing and executing on our PR program."
About Invida Group Pte Ltd.
Invida improves the lives of patients in Asia by commercializing differentiated pharmaceutical products of superior quality - the result of which will allow all Invida stakeholders to prosper. This is done through proven brand marketing and sales know-how, strong expertise across a number of key therapeutic categories and deep experience in all critical Asian markets. Comprehensive functional capabilities provide rapid market access delivered by passionate team of professionals.
With 4,000 employees in 13 markets in Asia Pacific, Invida operates across the commercial value chain from regulatory approval and product launch to lifecycle management. We manage a portfolio of proprietary healthcare brands as well as licensed products from small biotech firms and large multinational companies. Partnering is a critical component of Invida's business model. We collaborate closely with our partners in developing effective strategies and put our extensive experience behind maximizing the potential of the assets entrusted to us.
Invida Group is a wholly-owned subsidiary of Invida Holdings.
For more information on Invida, please see www.invida.com.
About LaVoie Group, Inc.
LaVoie Group partners with leading life sciences brands to build their companies, attract capital, and reach key stakeholders through integrated communications programs. We provide senior-level counsel to our clients, create visibility, and develop strategies and implementation tactics for corporate and/or product programs on a global scale.
Our clients are industry leaders in life sciences and pharmaceuticals such as Pfizer Inc., sanofi-aventis, Aegerion Pharmaceuticals, Alphatec Spine, Invida Holdings, Vertex Pharmaceuticals and Rockwell Medical. LaVoie Group is ranked by O'Dwyer's PR Report as one of the leading independent healthcare PR firms in the U.S. and has been honored by the LACP as "Boutique Agency of the Year" in both 2008 and 2009. For more information, please visit http://www.lavoiegroup.com.
SOURCE LaVoie Group
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article